HALOZYME THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.71 USD | -1.50% |
|
+3.62% | +20.97% |
| May. 07 | Halozyme Therapeutics Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed | MT |
| May. 07 | Transcript : Halozyme Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Bio Therapeutic Drugs | -1.50% | +3.62% | +20.97% | +33.62% | +186.42% | 5.69B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- HALO Stock
- Charts Halozyme Therapeutics, Inc.
- Comparison Chart